<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>transplantasyon &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/transplantasyon/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 20 Jan 2026 21:19:04 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>transplantasyon &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Advancing Surgical Approaches for Hepatocellular Carcinoma</title>
		<link>https://bioengineer.org/advancing-surgical-approaches-for-hepatocellular-carcinoma/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 20 Jan 2026 21:18:40 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[cerrahi yaklaşımların geliştirilmesi). 3. **]]></category>
		<category><![CDATA[HCC surgical treatments]]></category>
		<category><![CDATA[Hepatocellular Carcinoma]]></category>
		<category><![CDATA[hepatocellular carcinoma surgical innovations]]></category>
		<category><![CDATA[liquid biopsy diagnostics]]></category>
		<category><![CDATA[liquid biopsy for HCC recurrence monitoring]]></category>
		<category><![CDATA[multidisciplinary cancer care **Açıklama:** 1. **Hepatocellular carcinoma:** Makalenin ana konusu. 2. **HCC surgical treatments:** Başlık ve içeriğin temel odağı (rezeksiyon]]></category>
		<category><![CDATA[multidisciplinary HCC treatment strategies]]></category>
		<category><![CDATA[perioperative immunotherapy in liver cancer]]></category>
		<category><![CDATA[precision oncology for hepatocellular carcinoma]]></category>
		<category><![CDATA[precision oncology HCC]]></category>
		<category><![CDATA[transplantasyon]]></category>
		<guid isPermaLink="false">https://bioengineer.org/advancing-surgical-approaches-for-hepatocellular-carcinoma/</guid>

					<description><![CDATA[Hepatocellular carcinoma (HCC), which emerges as the predominant form of liver cancer worldwide, is recognized as a leading contributor to cancer-related mortality. The challenge in effectively managing this malignancy is exacerbated by the typically high recurrence rates after surgical interventions, such as resection, which can surge to approximately 70% within a five-year time frame. Additionally, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">319159</post-id>	</item>
	</channel>
</rss>
